Sublingual formulation of riluzole
US11660267B2 · kind B2 · utility
4Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2015 |
| Grant date | May 30, 2023 |
| Priority date | — |
| Expiry date | Mar 10, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is sublingual administration of riluzole. In particular, a method for treating a neuropsychiatric disorder or symptom by administering a sublingual formulation of riluzole is provided. In addition, a method of relieving or reducing oral pain using the sublingual formulation of riluzole is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.